A detailed history of S.A. Mason LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, S.A. Mason LLC holds 9,628 shares of NVO stock, worth $1.02 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
9,628
Previous 9,628 -0.0%
Holding current value
$1.02 Million
Previous $1.37 Million 16.59%
% of portfolio
0.62%
Previous 0.8%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $247,923 - $330,013
2,428 Added 33.72%
9,628 $1.24 Million
Q4 2023

Jan 17, 2024

SELL
$87.78 - $105.45 $26,334 - $31,635
-300 Reduced 4.0%
7,200 $744,000
Q3 2023

Oct 13, 2023

BUY
$90.94 - $199.54 $341,025 - $748,275
3,750 Added 100.0%
7,500 $682,000
Q2 2022

Jul 07, 2022

SELL
$103.24 - $121.81 $15,486 - $18,271
-150 Reduced 3.85%
3,750 $418,000
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $363,090 - $438,906
3,900 New
3,900 $433,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track S.A. Mason LLC Portfolio

Follow S.A. Mason LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.